analyzed data from 524 families with PALB2 pathogenic variants from 21 countries and found an association between PALB2 and risk of male breast cancer (RR = 7.34, 95% CI: 1.28-42.18, p = 0.026) (39). The gene discussed is PALB2; the disease is breast carcinoma.